The Pharmaceutical Journal examines personalised treatment to depression including P1vital® PReDicT Test which is being used in the PReDicT randomised clinical trial across 5 European countries.
If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.